Recombinant luteinizing hormone as a survival and differentiation factor increases oocyte maturation in recombinant follicle stimulating hormone-supplemented mouse preantral follicle culture

By Cortvrindt R   Hu Y   Smitz J  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1292-1302

Oxford University Press

Access to resources Recommend Favorite

Continuing the debate on empty follicle syndrome: can it be associated with normal bioavailability of β-human chorionic gonadotrophin on the day of oocyte recovery?

By Awonuga A   Govindbhai J   Zierke S   Schnauffer K  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1281-1284

Oxford University Press

Access to resources Recommend Favorite

Mouse oocyte meiotic resumption and polar body extrusion in vitro are differentially influenced by FSH, epidermal growth factor and meiosis-activating sterol

By Coticchio G.  

Human Reproduction, Vol. 19, Iss. 12, 2004-12 ,pp. : 2913-2918

Oxford University Press

Access to resources Recommend Favorite

Andrology. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men

By Liu Peter Y.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1540-1545

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin: Case report

By Peñarrubia J.   Balasch J.   Fábregues F.   Creus M.   Cívico S.   A.Vanrell J.  

Human Reproduction, Vol. 14, Iss. 7, 1999-07 ,pp. : 1703-1706

Oxford University Press

Access to resources Recommend Favorite